Summary
For Year 2026-27, Vivanza Biosciences reports the following shareholding: Total Promoters at 20.02%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 79.98%. This breakdown provides a quick snapshot of ownership distribution for Vivanza Biosciences in 2026-27.
Vivanza Biosciences FAQs
As of 04-2026, the promoter shareholding in Vivanza Biosciences stands at 20.02% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Vivanza Biosciences is 0% and 0% respectively.
The retail shareholding of the Vivanza Biosciences is 79.98%.
Changes in shareholding patterns of Vivanza Biosciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Vivanza Biosciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
